Analyst Profile

Followed by 291 followers
.
Michael Matson

Michael Matson

Needham
Wall Street Analyst
#5,259 out of 8,141 Wall Street Analysts
#15,006 out of 24,284 experts

Success Rate

47%
198 out of 419 transactions made a profit

Average Return

-0.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Michael Matson's trades since 2009 and holding each position for 1 Year would result in 47.26% of your transactions generating a profit, with an average return of -0.1% per rating.

Stock Rating Distribution

2KRatings
71.23% Buy
26.77% Hold
2.00% Sell
Distribution of Michael Matson's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
GenMark Diagnostics
(GNMK)
Rating:Buy
Date:Apr 07, 2020 - Mar 15, 2021
Return:+432.80%
The most profitable rating made by Michael Matson

Michael Matson's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
Orthofix
Apr 17, 2009
Sell
Downgraded
1Ratings
0.00%
MAKO
Mako Surgical
Apr 09, 2013
Buy
Upgraded
4Ratings
0.00%
Intuitive Surgical
Apr 19, 2013
Buy
Reiterated
$636.00
(139.88% Upside)
1Ratings
0.00%
COV
Covidien
Jul 17, 2014
Hold
Downgraded
4Ratings
0.00%
VOLC
Volcano Corp
Dec 17, 2014
Hold
Downgraded
3Ratings
0.00%
ARTC
ArthroCare
Sep 23, 2015
Buy
Reiterated
1Ratings
0.00%
ADMA Biologics
Nov 06, 2015
Buy
Reiterated
$1.00
(-69.23% Downside)
1Ratings
0.00%
EXAM
Examworks Group
Jul 19, 2016
Hold
Reiterated
18Ratings
0.00%
CPHD
Cepheid
Oct 11, 2016
Hold
Reiterated
16Ratings
0.00%
Sintx Technologies
Nov 11, 2016
Buy
Reiterated
10Ratings
0.00%
List of latest recommendations made by Michael Matson. Click to expand and see Michael Matson's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >